Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Syndax Pharmaceuticals

Clinical trials sponsored by Syndax Pharmaceuticals, explained in plain language.

Syndax Pharmaceuticals SNDX NASDAQ

A biopharmaceutical company developing cancer therapies, including treatments for leukemia and other malignancies.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 3 Not yet finished but already full! 3 Completed 1 Terminated 1

New antibody shows promise for Hard-to-Treat GVHD

Disease control Completed

This trial tested a drug called axatilimab in 41 people with chronic graft-versus-host disease (cGVHD), a complication of stem cell transplants where donor cells attack the patient's body. Participants had already tried at least two other treatments. The study aimed to find a saf…

Phase: PHASE1, PHASE2 • Sponsor: Syndax Pharmaceuticals • Aim: Disease control

Last updated Jun 26, 2026 17:19 UTC